Bayesian Capital Management’s LivaNova LIVN Stock Holding History

Bayesian Capital Management’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,700	Closed	-$218K	–	801
2024 Q4	$218K	Buy	+4,700	New	+$241K	0.03%	550
2024 Q2	–	Sell	-7,100	Closed	-$397K	–	940
2024 Q1	$397K	Buy	+7,100	New	+$369K	0.04%	488
2022 Q3	–	Sell	-6,419	Closed	-$401K	–	887
2022 Q2	$401K	Buy	+6,419	New	+$455K	0.07%	393
2022 Q1	–	Sell	-2,466	Closed	-$216K	–	849
2021 Q4	$216K	Buy	+2,466	New	+$206K	0.07%	308
2020 Q3	–	Sell	-4,900	Closed	-$236K	–	619
2020 Q2	$236K	Buy	+4,900	New	+$246K	0.05%	402
2018 Q1	–	Sell	-6,722	Closed	-$537K	–	722
2017 Q4	$537K	Sell	6,722 -1,200	-15%	-$95.3K	0.11%	298
2017 Q3	$555K	Buy	+7,922	New	+$502K	0.13%	249
2016 Q4	–	Sell	-4,900	Closed	-$295K	–	651
2016 Q3	$295K	Buy	+4,900	New	+$282K	0.19%	200

Other funds holding LIVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bayesian Capital Management's LIVN Position: Q1 2025 in Review

Bayesian Capital Management sold out of LivaNova (LIVN) in Q1 2025, closing a stake of 4,700 shares — an estimated $218K sold.

Bayesian Capital Management first reported a position in LIVN in Q3 2016 and held it in 8 quarters. The position peaked at $555K in Q3 2017. 249 funds tracked by Wall St. Rank hold LIVN as of Q1 2025.

Bayesian Capital Management reported no remaining LivaNova position as of Q1 2025 after selling out during the quarter.
Bayesian Capital Management sold 4,700 LivaNova shares in Q1 2025, an estimated $218K.
Bayesian Capital Management first reported a position in LivaNova in Q3 2016 and held it in 8 quarters.
Bayesian Capital Management's LivaNova position peaked at $555K in Q3 2017.
249 funds tracked by Wall St. Rank held LivaNova as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.